Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | VAMP2 |
| Upstream (Parents) |
|---|
| (<<) SIGIRR → VAMP2 |
| (<<) HHLA3 → VAMP2 |
| (<<) NRIP1 → VAMP2 |
| (<<) RFNG → VAMP2 |
| (<<) TTC23 → VAMP2 |
| Downstream (Children) |
|---|
| VAMP2 → RPS11 (>>) |
| VAMP2 → MMP15 (>>) |
| VAMP2 → PHLPP1 (>>) |
| VAMP2 → STAMBPL1 (>>) |
| VAMP2 → SLC17A6 (>>) |
| VAMP2 → ANKRD53 (>>) |
| VAMP2 → SYT12 (>>) |
| VAMP2 → SLC7A4 (>>) |
| VAMP2 → KRT34 (>>) |
| VAMP2 → CHI3L2 (>>) |
| VAMP2 → CCIN (>>) |
| VAMP2 → ABCA2 (>>) |
| VAMP2 → NEURL (>>) |
| VAMP2 → TNR (>>) |
| VAMP2 → FRAS1 (>>) |
| VAMP2 → STOML1 (>>) |
| VAMP2 → PRR5 (>>) |
| VAMP2 → RPL10L (>>) |
